Skip to main content

Experimental Hematology & Oncology

Ausgabe 1/2020

Inhalt (36 Artikel)

Open Access Research

The SMAC mimetic LCL-161 selectively targets JAK2V617F mutant cells

Brianna M. Craver, Thanh Kim Nguyen, Jenny Nguyen, Hellen Nguyen, Christy Huynh, Sarah J. Morse, Angela G. Fleischman

Open Access Review

Clinical implications of recurrent gene mutations in acute myeloid leukemia

Jifeng Yu, Yingmei Li, Danfeng Zhang, Dingming Wan, Zhongxing Jiang

Open Access Research

Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

Binglei Zhang, Jian Zhou, Fengkuan Yu, Tianxin Lv, Baijun Fang, Dandan Fan, Zhenyu Ji, Yongping Song

Open Access Research

Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis

Shih-Hsuan Chao, Yuh-Lih Chang, Jiin-Cherng Yen, Hsien-Tzung Liao, Tsai-Hung Wu, Chia-Li Yu, Chang-Youh Tsai, Yueh-Ching Chou

Open Access Research

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial

Vivek Subbiah, Ecaterina Ileana Dumbrava, Yunfang Jiang, Kyaw Z. Thein, Aung Naing, David S. Hong, Siqing Fu, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Filip Janku, Funda Meric-Bernstam, Razelle Kurzrock, Gerald Falchook

Open Access Research

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma

Xi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, Lissa Hooi, Tan Boon Toh, Johann Shane Tian, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Bte Meera Sahib, Mengjie Gu, Jhin Jieh Lim, Wilson Wang, Wee Joo Chng, Sudhakar Jha, Edward Kai-Hua Chow

Open Access Letter to the Editor

The effects of B cell depletion on immune related adverse events associated with immune checkpoint inhibition

Rasmus Strøm Risbjerg, Mie Vennize Hansen, Anne Sofie Sørensen, Tue Wenzel Kragstrup

Open Access Research

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma

Furong Liu, Lu Qin, Zhibin Liao, Jia Song, Chaoyi Yuan, Yachong Liu, Yu Wang, Heze Xu, Qiaofeng Zhang, Youliang Pei, Hongwei Zhang, Yonglong Pan, Xiaoping Chen, Zhanguo Zhang, Wanguang Zhang, Bixiang Zhang

Open Access Research

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes

Liqing Kang, Xiaowen Tang, Jian Zhang, Minghao Li, Nan Xu, Wei Qi, Jingwen Tan, Xiaoyan Lou, Zhou Yu, Juanjuan Sun, Zhenkun Wang, Haiping Dai, Jia Chen, Guoqing Lin, Depei Wu, Lei Yu

Open Access Short report

Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation

Jingjing Wu, Shundong Cang, Christina Liu, Whitman Ochiai, Jen Wei Chiao

Open Access Research

RDGN-based predictive model for the prognosis of breast cancer

Bing Dong, Ming Yi, Suxia Luo, Anping Li, Kongming Wu

Open Access Research

Leukemia incidence trends at the global, regional, and national level between 1990 and 2017

Ying Dong, Oumin Shi, Quanxiang Zeng, Xiaoqin Lu, Wei Wang, Yong Li, Qi Wang

Open Access Review

Macrophage, the potential key mediator in CAR-T related CRS

Zhaonian Hao, Ruyuan Li, Li Meng, Zhiqiang Han, Zhenya Hong

Open Access Research

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China

Yanhui Chen, Yating Wang, Hongli Luo, Xue Meng, Wei Zhu, Di Wang, Hui Zeng, Henghui Zhang

Open Access Letter to the Editor

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models

Pei Pei Che, Alessandro Gregori, Omidreza Firuzi, Max Dahele, Peter Sminia, Godefridus J. Peters, Elisa Giovannetti

Open Access Letter to the Editor

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study

Il Seok Daniel Jeong, Huan Mo, Anthony Nguyen, Esther G. Chong, Hsin Hsiang Clarence Tsai, Justin Moyers, Matthew Kim, Curtis Lacy, Vivek Shah, Eric Lau, Yi Xu, Huynh Cao

Open Access Research

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study

Immacolata Tartaglione, Raffaella Origa, Antonis Kattamis, Michael Pfeilstöcker, Sibel Gunes, Susanne Crowe, Niamh Fagan, Beatrice Vincenzi, Giovan Battista Ruffo

Open Access COVID-19 Research

Risk factors and outcome of COVID-19 in patients with hematological malignancies

José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Gonzalo Benzo, Irene Gómez-Catalan, Rosa Coll, Ignacio De La Fuente, Alejandro Luna, Beatriz Merchán, Anabelle Chinea, Dunia de Miguel, Ana Serrano, Carmen Pérez, Carola Diaz, José Luis Lopez, Adolfo Jesús Saez, Rebeca Bailen, Teresa Zudaire, Diana Martínez, Manuel Jurado, María Calbacho, Lourdes Vázquez, Irene Garcia-Cadenas, Laura Fox, Ana I. Pimentel, Guiomar Bautista, Agustin Nieto, Pascual Fernandez, Juan Carlos Vallejo, Carlos Solano, Marta Valero, Ildefonso Espigado, Raquel Saldaña, Luisa Sisinni, Josep Maria Ribera, Maria Jose Jimenez, Maria Trabazo, Marta Gonzalez-Vicent, Noemí Fernández, Carme Talarn, Maria Carmen Montoya, Angel Cedillo, Anna Sureda

Open Access Research

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells

Yong-Rim Kwon, Hye Joung Kim, Min-Jung Sohn, Ji-Young Lim, Kyung-Shin Park, Seok Lee, Nack-Gyun Chung, Dae-Chul Jeong, Chang-Ki Min, Yoo-Jin Kim

Open Access Review

Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer

Mengqi Liu, Wensheng Liu, Yi Qin, Xiaowu Xu, Xianjun Yu, Qifeng Zhuo, Shunrong Ji

Open Access COVID-19 Letter to the Editor

Frontiers in the COVID-19 vaccines development

Ehtisham Ul Haq, Jifeng Yu, Jiancheng Guo

Open Access Research

miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR

Luhui Lin, Yiqun Huang, Wei Zhuang, Ping Lin, Xudong Ma

Open Access Research

The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017

Xianguang Bai, Ming Yi, Bing Dong, Xinhua Zheng, Kongming Wu

Open Access Research

Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study

Liqing Ning, Chuanyu Hu, Pingfan Lu, Yimei Que, Xiaojian Zhu, Dengju Li

Open Access Review

Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma

Caiqin Xie, Xian Li, Hui Zeng, Wenbin Qian

Open Access Review

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia

Ruyue Zheng, Menglin Li, Shujuan Wang, Yanfang Liu

Open Access Review

Complex roles of cAMP–PKA–CREB signaling in cancer

Hongying Zhang, Qingbin Kong, Jiao Wang, Yangfu Jiang, Hui Hua

Open Access Review

Engineering better chimeric antigen receptor T cells

Hao Zhang, Pu Zhao, He Huang

Open Access Review

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation

Jifeng Yu, Hao Sun, Weijie Cao, Lijie Han, Yongping Song, Dingming Wan, Zhongxing Jiang

Open Access Review

CD44 as a tumor biomarker and therapeutic target

Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu, Aiguo Liu

Open Access Letter to the Editor

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

Ana Muntañola, Guillermo Villacampa, José Ángel Hernández-Rivas, Rosalía Alonso, Fátima Mirás, Santiago Osorio, Mónica Baile, Patricia Baltasar, Javier López Jiménez, Ines Hernandez-Rodriguez, Susana Valenciano, Ana Alfayate, Eva Gimeno, Abelardo Bárez, Ana C. Oliveira, Rosalía Riaza, Pilar Romero, Julio Delgado, Lucrecia Yáñez, Amaya Zabalza, Ana Torres, Mª Isabel Gómez-Roncero, Marta Crespo, Raúl Córdoba, Juan José Mateos-Mazón, Sonia Pérez, Rafael Andreu, Jorge Labrador, Mª Elena Ruiz, César Andrés Velasquez, Mª José Terol, Raquel Santiago, Mª Jesús Vidal, Fiz Campoy García, Lucía Villalón, Begoña S. Muiña, Joan Alfons Soler, Cristina Seri, Mª José Sánchez, Amalia Cuesta, Rafael Ramos, Adrián Sánchez-Montalvá, Isabel Ruiz-Camps, Marcos González, Pau Abrisqueta, Francesc Bosch

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.